| Health / Medical Topics |
Everolimus/Gefitinib
A chemotherapy drug combination consisting of everolimus and gefitinib. Everolimus is a proliferation inhibitor with immunosuppressive and anti-angiogenic properties. Gefitinib is an epidermal growth factor receptor (EGFR) inhibitor with anti-angiogenic activity. This combination chemotherapy may result in increased tumor cell death compared to the use of either agent alone. (NCI Thesaurus)
YOU MAY ALSO LIKE
Tablets for oral suspension containing everolimus, a derivative of the natural macrocyclic lactone sirolimus, with immunosuppressive and antineoplastic activities. After suspension of…
A drug used with another drug to treat some postmenopausal women with advanced breast cancer that is hormone-receptor positive and HER2…
On May 29, 1953, Edmund Hillary, from New Zealand, and Tenzing Norgay, from Nepal, became the first humans to successfully climb to…
At any time in the past, present, or future.
A data type comprised of an interval of time over which an event or activity occurs.
In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or…
